SynthesisJournal of foot and ankle research2026
Malignant Melanoma Misdiagnosis in the Diabetic Foot. What Can We Learn From the Published Literature?
Synthesis in Journal of foot and ankle research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe foot is an independent risk factor for a poorer prognostic outcome in melanoma. Delayed diagnosis may arise because melanoma mimics other benign diagnoses, such as ulceration on the foot, including those with associated with diabetes. Improving outcomes for patients includes raising awareness amongst professionals involved in diabetic foot care. Evaluation of published case studies may help identify common themes to inform practice and improve recognition and referral for lesions requiring biopsy.
methodsThe authors undertook a systematic literature search of PubMed (National Library of Health) (2010-2025) to identify published case studies reporting delayed diagnosis or misdiagnosis of melanoma arising on the skin of the foot or in the toenail in patients with diabetes. Data were collated and tabulated to give basic demographics and assist in identification of common themes. A structured content analysis was undertaken to inform key aspects regarding missed diagnosis.
resultsFollowing a systematic search of the literature, 1485 papers were identified. After removal of duplicates and irrelevant papers, a total of 86 case studies were identified. A total of 20 cases were reported in patients with diabetes (reported in 19 papers) from 10 countries, including 14 males and 7 females (average age 73 years), with a mean Breslow thickness of 3.58 mm. Melanoma lesions were located on the heels (n = 8), forefoot (n = 5), toes (n = 3), subungual regions (n = 2) and in the arch (n = 2). The most common misdiagnosis was a diabetic foot ulcer (n = 17).
conclusionBased on the reviewed cases, distinguishing melanoma from diabetic foot ulceration (DFU) is difficult. Common themes from the content analysis suggest that clues such as ulceration despite lack of the corresponding risk factors, hypergranulation and lack of improvement to be key aspects to suggest an alternative diagnosis. The authors propose a simple acronym, 'U.L.C.E.R', as an aide-mémoire to assist healthcare professionals in the identification of potential melanoma masquerading as DFU.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.